At CILS International, we believe that a label is a commitment to quality, durability, and innovation. For over four decades, we’ve been at the forefront of the labelling industry, consistently pushing boundaries and setting new standards. Our journey has been marked by a series of pioneering developments that have shaped the way industries identify, trace, and comply with the strictest standards.

Pioneering Innovations

Our journey began in 1987 with the introduction of computer imprintable label systems—a revolutionary step in labelling technology. This innovation allowed for stand-alone printing machines with integrated keyboards, screens, and durable labels, setting the stage for future advancements. But we didn’t stop there. Over the years, we’ve continued to innovate, consistently leading the way in the development of new labelling technologies. 

• 1990: We launched the first laser-printable durable labels, enabling our customers to produce high-quality, long-lasting labels with unprecedented ease.
• 1994: We introduced a range of Thermal Transfer printable durable labels, further expanding the possibilities for durable labelling in various industries.
• 2000: We launched our durable laboratory and biotech range, catering to the specific needs of the scientific community.
• 2004: Our labels played a crucial role in clinical trials for the world’s largest flu vaccine manufacturer, ensuring that all samples were accurately identified and traced.
• 2010: CILS labels made their way to space, being used on the International Space Station, a testament to our labels’ reliability in extreme conditions.
• 2016: CILS 3.0^® print technology was introduced and UL approved, this cutting-edge development enabled the production of industry-leading quality graphics and set a new benchmark for clarity. 

Meeting Global Challenges

Our commitment to innovation is matched by our dedication to supporting global health and safety initiatives. In 2020, we were awarded critical supplier status by UK and USA governmental health protection agencies, recognising our essential role in the fight against the COVID-19 pandemic. The following year, we supplied labels for the World Health Organisation’s largest COVID-19 vaccine efficacy study, further solidifying our reputation as a trusted partner in the global healthcare sector.

The Future of Labelling

Today, CILS continues to manufacture millions of labels each month, serving over 15,000 customers worldwide. We are ISO-accredited and our products are UL-approved, and trusted by industries across the globe. As we look to the future, we remain committed to pushing the boundaries of what’s possible in labelling technology, ensuring that our customers can continue to rely on us to meet their most challenging identification, traceability, and compliance needs.

At CILS, we don’t just make labels; we make labels that last.